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Abstract. Viscum album L. is a parasitic plant that grows on various trees, commonly 
known as European mistletoe. In the present study, the antitumor effects of mistletoe have 
been assessed. The model of choice was Ehrlich Ascites Carcinoma (EAC), which was 
inoculated in Swiss female mice. The Viscum album (VA) therapy was applied before and 
after EAC inoculation, and the results were both compared to EAC inoculated alone and with 
doxorubicin treated groups. In EAC injected animals, VA significantly increased the WBC 
count and the granulocytes number; while in the animals receiving VA before EAC 
administration, the plant extract seems to provide a lesser effect. The antiproliferative effect 
of VA was stronger in pretreated group, manifested by a lower cellular concentration, and a 
higher percentage on non-viable tumor cells.   
 




Viscum album L. is a parasitic plant that grows on various trees. It is commonly 
known as European mistletoe. Viscum album preparations are used as a complementary 
medicine in cancer therapy. Although the beneficial properties of European mistletoe have 
been documented throughout history, its therapeutic application has been changing with the 
development of science. 
Recently, many in vitro and in vivo studies have examined the antitumor properties of 
Viscum album extracts or certain constituents isolated from these extracts (Cebovic et al., 
2008, Khil et al., 2007). It is thought that the molecular basis of the antitumoral activity of 
mistletoe lies in two distinct bioactivities. First, its lectin content is responsible for direct 
toxicity to tumor cells (Khil et al., 2007). Secondly, the Viscum album rhamnogalacturonan 
oligosaccharide favours bridging of natural killer tumor cell conjugates, enhancing the 
cytotoxic efficiency. Moreover, it has been found that the antitumoral human cytotoxic T 
lymphocytes with CD T cell receptor are selectively activated by mistletoe ligands of 
phosphoantigen structure (Tabiasco et al., 2002). 
The aim of the present study is to assess the antitumor properties of local harvested 




MATERIALS AND METHODS 
 
Plant materials: The Viscum album (plant raised from the apple tree – Malus 
communis) was harvested from Cluj area, in November – December 2009. The vegetal 
products were dried and grounded to a fine powder. 
Preparation of tinctures: The Viscum album L. was prepared according to European 
Pharmacopoeias, method 2a, by cold extraction (maceration). 100 g of fresh Viscum album L. 
plant was cut to a pasta consistency (moisture 70 %). To cut plant material was adding 70 g 
90 % vol. ethanol. The plant-ethanol mixture was macerate 10 days with periodical mixing 
and then pressed and filtered. The extraction ratio was 1:1 plant to extract (mother tincture). 
The obtained mother tincture has 8.5 % dry residue. 
To prevent toxic effect of the alcohol, often more toxic than plant compounds 
dissolved in it, alcoholic solution was maintained in a water bath until 3/4 of the content 
evaporates, than filed with sterile saline solution up to 0.5 ml / animal. The aqueous solution 
was administrated i.p., immediately, in order to prevent the bacterial and fungus 
contamination. 
The animals were caged in groups of 8 per cage, at controlled temperature of 21-22ºC, 
humidity (40-60%) and reversed 12/12h light/dark cycle (light off at 10 a.m.). Standard lab 
chow, provided by National Institute for Research and Development “Cantacuzino” Bucharest 
(Batch no. 2 / 26.03.2010), and water were freely available. The animal tests and experiments 
were allowed by the Bioethical Board of the Faculty of Veterinary Medicine Cluj-Napoca. 
The experiment was carried out on 48 white Swiss female mice, 35.65 ±0.54 g body 
weight. The animals were divided in six equal experimental groups. The first group was the 
Control, the second one received Viscum album (VA) extract i.p. in the day 1, 3 and 6 - 50 mg 
d.s./kg b.w. (Viscum album 1:1 plant to extract in ethylic alcohol 70°). The third received 
Ehrlich Ascitic Carcinoma (EAC), and the fourth was inoculated with EAC and received 
treatment with Doxorubicin (EAC + D). The last two groups were also inoculated with EAC, 
one was treated with VA three times at 6, 3 and 1 day before the inoculation; the other one 
received VA in the days 1, 3 and 6 after, in the same dose as the VA group. 
EAC groups received 10
6
 ascitic cells/animal intra peritoneal, in the day 0, and the 
experiment spanned for 14 days. Ehrlich ascitic carcinoma (EAC) was a generous gift from 
the Oncology Institute “I. Chiricuţă” Cluj Napoca. Body weight was measured at the 
beginning, and at the end of experiment. 
The Control group received 0.5 ml alcohol 70°, i.p (after evaporation in water bath in 
the same way like the plant extracts) and the EAC+D group received i.p. Doxorubicin 
chloride 2.5 mg/ kg b.w. (Adriablastina 10 mg – Pfizer) in day1 and 6 of the experiment. 
In the end, the blood was harvested from the retro orbitary sinus under diethyl ether 
anaesthesia and the euthanasia was made by prolonged ether narcosis. Total amount of ascitic 
fluid was measured, and viable tumor cell concentration was counted in a Burker camera 
(liquid diluted 1:100). Cell viability was assessed by tripan blue staining (Olinescu, 1992). 
Blood hematology was investigated with Abacus Junior Vet, automatic analyzer 
Diatron Messtechnik, Budapest, Hungary. 
Statistics - the data were expressed as the mean and standard error of the mean (SEM). 
T Student multiple range test from Excel Windows Software was used to assess the 
differences among groups. Differences at p<0.05 and p<0.01 were considered significant and 




RESULTS AND DISCUSSION 
 
The development of EAC was responsible for anemia in tumor bearing mice. The 
differences were seen mainly in RBC total count and HCT (Tab.1), the anemia was 
responsible for increased anisocytosis despite the fact that the RBC indices remained in 
normal range (Tab.2). Injected alone or after the EAC inoculation, the Viscum album L. (VA) 
extract was unable to influence the RBC count, HGB or HCT (Tab.1), however injected 6 




The effect of Viscum album alcoholic extract on the values of the red blood cells (RBCs), 




/l HGB g/l HCT % 
Control 8.00±0.47 128.83±7.95 38.58±1.98 
EAC 6.52±0.49 107.80±7.86 31.78±1.91* 
EAC + Doxorubicin 7.14±0.59 110.38±9.64 33.51±2.75 
EAC + V. album 6.91±0.25 113.70±4.43 32.71±1.49 
V. album + EAC 5.67±0.66    90.62±11.8 27.46±3.12 
V. album 8.16±0.22 133.87±3.42 39.13±0.80 
 
EAC – Ehrlich ascites carcinoma inoculated group, EAC + Doxorubicin - Ehrlich ascites 
carcinoma inoculated group treated with doxorubicin chloride, EAC + V. album - Ehrlich 
ascites carcinoma inoculated group treated with Viscum album alcoholic extract after EAC 
inoculation, V. album + EAC - Ehrlich ascites carcinoma inoculated group treated with 
Viscum album alcoholic extract before EAC inoculation, V. album - group treated with 
Viscum album alcoholic extract,  
*= p<0.05 as compared to Control group 
Normal values:  
RBC 7-12.5 10
12
/l, HGB 102-180 g/L, HCT 36-49 % MCV 53.6-56 fl MCH 48.1-50 pg 
MCHC 31.3-33.2 g/dl  
WBC 6-15 10
9
/l (Uray Z., 1992) 
 
The EAC inoculation was associated with significant leukocytosis, the granulocytes 
were in a very high number (neutrophilia), and middle cells were also increased. Doxorubicin 
administration down-regulates the leukocytosis throughout reduction of granulocytes 
synthesis. Injected alone, VA was not able to influence the WBC profile as compared to 
control. In EAC injected animals, VA (injected after EAC inoculation) significantly increased 
the WBC count and consequently the granulocytes number but not in significant manner. In 
the animals receiving VA 6 days before EAC administration, the plant extract seems to 
provide a lesser effect; WBCs count and neutrophils remains unchanged, but middle cells 
were significantly increased as compared to EAC group. Lymphocytes were also increased 
but not in significant manner. The significance remains obscure probably due to an enhanced 






The effect of Viscum album alcoholic extract on the values of mean corpuscular volume 
(MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration 
(MCHC) and red blood cells distribution width (RDW) (mean ± S.E.M) 
 
 MCV fl MCH pg MCHC g/dl RDWs fl 
Control 48.33±0.49 16.08±0.19 332.00±5.07 17.08±0.16 
EAC 
49.75±1.90 16.62±0.38 339.75±6.86 19.53±0.63*
* 
EAC + Doxorubicin 47.38±1.14 15.5±0.47† 328.00±5.03 19.84±0.72 
EAC + V. album 47.33±0.88 16.43±0.12 347.00±5.24 17.98±0.64 
V. album + EAC 49.00±1.50 15.85±0.62 309.75±14.3† 18.99±0.96 
V. album 47.86±0.93 16.38±0.25 341.37± 2.63 16.78±0.18 
EAC – Ehrlich ascites carcinoma inoculated group, EAC + Doxorubicin - Ehrlich ascites 
carcinoma inoculated group treated with doxorubicin chloride, EAC + V. album - Ehrlich 
ascites carcinoma inoculated group treated with Viscum album alcoholic extract after EAC 
inoculation, V. album + EAC - Ehrlich ascites carcinoma inoculated group treated with 
Viscum album alcoholic extract before EAC inoculation, V. album - group treated with 
Viscum album alcoholic extract, 
*= p<0.05, **= p<0.01, as compared to Control group 




/l, HGB 102-180 g/L, HCT 36-49 % MCV 53.6-56 fl MCH 48.1-50 pg 
MCHC 31.3-33.2 g/dl, WBC 6-15 10
9
/l (Uray Z., 1992) 
 
Tab. 3 
The effect of Viscum album alcoholic extract on the WBC count and differential count  











Control   6.85±0.74 5.08±0.62 0.18±0.02   1.59±0.17 
EAC 21.98±5.19* 5.73±0.94 0.61±0.14* 15.62±4.79* 
EAC + Doxorubicin 12.32±5.09† 4.38±0.82 0.35±0.10    7.59±4.29† 
EAC + V. album 55.7±19.54 8.40±2.82 0.90±0.38 29.54±11.49 
V. album + EAC 23.39±2.66 7.43±1.15 1.09±0.11† 14.83±2.07 
V. album    6.80±0.76 4.82±0.55 0.23±0.10   1.75±0.19 
EAC – Ehrlich ascites carcinoma inoculated group, EAC + Doxorubicin - Ehrlich ascites 
carcinoma inoculated group treated with doxorubicin chloride, EAC + V. album - Ehrlich 
ascites carcinoma inoculated group treated with Viscum album alcoholic extract after EAC 
inoculation, V. album + EAC - Ehrlich ascites carcinoma inoculated group treated with 
Viscum album alcoholic extract before EAC inoculation, V. album - group treated with 
Viscum album alcoholic extract 
*= p<0.05 as compared to Control group 




/l, HGB 102-180 g/L, HCT 36-49 % MCV 53.6-56 fl MCH 48.1-50 pg 
MCHC 31.3-33.2 g/dl, WBC 6-15 10
9
/l (Uray Z., 1992) 
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The previous studies confirm that mistletoe extract improves the immune response in 
EAC inoculated mice not due to peritoneal irritation, but only if it is administrated after the 
EAC inoculation (Sevastre et al., 2010), no studies regarding the influence of Viscum album 
L. on WBCs before EAC inoculation were found.  
The EAC development was as expected, followed by the increase in body weight, 
while doxorubicin provided a strong protective effect (Tab.4). VA, administrated before and 
after EAC inoculation, did not influence the variation of body weight in EAC inoculated mice 
(Tab.4). However previous studies suggest some antiproliferative effect of VA extract, the 
treated animals revealed lower difference in body weight as compared to untreated ones 
(Sevastre et al., 2010). 
 
Tab. 4 
The effect of Viscum album alcoholic extract on body weight changes in EAC inoculated 
mice (mean ± S.E.M). 
 






Control 36.81±0.61 34.12±0.79 -2.68±0.87 -7.19±2.32 
EAC 29.75±0.40 39.93±1.79 10.19±1.61*** 34.12±5.21*** 
EAC+Doxorubicin 30.38±0.81 33.00±1.01 2.62±1.00†† 8.96±3.69†† 
EAC+V. album 33.58±0.69 45.00±4.67 11.42±2.27 34.51±7.05 
V. album + EAC 26.88±0.48 39.25±1.37 12.37±1.64 46.68±6.88 
 
EAC – Ehrlich ascites carcinoma inoculated group, EAC + Doxorubicin - Ehrlich ascites 
carcinoma inoculated group treated with doxorubicin chloride, EAC + V. album - Ehrlich 
ascites carcinoma inoculated group treated with Viscum album alcoholic extract after EAC 
inoculation, V. album + EAC - Ehrlich ascites carcinoma inoculated group treated with 
Viscum album alcoholic extract before EAC inoculation, V. album - group treated with 
Viscum album alcoholic extract, 
*** = p<0.001 as compared to Control group 
†† = p<0.01 as compared to EAC group 
 
The ascitic volume followed the trend of the body weight variation, therefore the 
doxorubicin treated groups shown very few amounts of ascitic fluid. The administration of 
VA has no obvious influence on the ascitic volume (Fig.1), despite the fact that literature data 
report the reduction of the ascitic fluid in a relevant manner following administration of 
mistletoe extract before EAC inoculation (Cebovic et al, 2008). The difference might be 





Fig. 1. The effect of Viscum album L alcoholic extract on the variation of the ascitic 
volume among experimental groups (mean ± S.E.M.) (ml) 
 
EAC – Ehrlich ascites carcinoma inoculated group, EAC + D - Ehrlich ascites carcinoma 
inoculated group treated with doxorubicin chloride, EAC + V - Ehrlich ascites carcinoma 
inoculated group treated with Viscum album alcoholic extract after EAC inoculation, V + 
EAC - Ehrlich ascites carcinoma inoculated group treated with Viscum album alcoholic 
extract before EAC inoculation 
†† = p<0.01 as compared to EAC group 
 
 
Fig. 2. The effect of Viscum album L alcoholic extract on the cellular concentration within 
ascitic fluid (mean ± S.E.M.) (10
6
/ml) 
EAC – Ehrlich ascites carcinoma inoculated group, EAC + D - Ehrlich ascites carcinoma 
inoculated group treated with doxorubicin chloride, EAC + V - Ehrlich ascites carcinoma 
inoculated group treated with Viscum album alcoholic extract after EAC inoculation, V + 
EAC - Ehrlich ascites carcinoma inoculated group treated with Viscum album alcoholic 
extract before EAC inoculation 
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The antiproliferative effect of VA was obvious in the cellular concentration is ascitic 
fluid, but this effect was found only in the group pre-treated with VA (Fig.2). Similar results 
were reported by Cebovic et al (2008), the previous administration of mistletoe extracts 
proved a significant protective effect in both males and females. Interestingly the post-treated 
animals showed higher cellular concentration in ascitic fluid similar to those found in EAC 
non-treated groups (Cebovic et al, 2008; Sevastre et al., 2010). 
The percentage of non-viable cells was in inverse proportion with the cellular 
concentration, and reached the highest levels in the VA pre-treated group, even though the 
ascitic volume was very close to the EAC untreated group (Fig.3). The present findings were 
confirmed by bibliographical data, which reports, in female groups, highly increased 
percentage of non-viable cells in pre-treated animals and almost unchanged percent, as 
compared to EAC group, in post-treated animals. Notable, a significant difference in non-
viable cell concentration between female groups and male groups may occur, but the 
explanation remains obscure (Cebovic et al, 2008). 
 
 
Fig. 3. The effect of Viscum album L alcoholic extract on the percentage of non viable 
cells (mean ± S.E.M.) (%) 
EAC – Ehrlich ascites carcinoma inoculated group, EAC + D - Ehrlich ascites carcinoma 
inoculated group treated with doxorubicin chloride, EAC + V - Ehrlich ascites carcinoma 
inoculated group treated with Viscum album alcoholic extract after EAC inoculation, V + EAC - 
Ehrlich ascites carcinoma inoculated group treated with Viscum album alcoholic extract before 
EAC inoculation 




In conclusion, the administration of VA extracts have a strong influence on WBC 
differential count mainly at the granulocytes level by up regulating the neutrophils reaction in 
EAC inoculated mice, suggesting an immunostimulatory effect. When VA was injected 
previously to EAC inoculation, the unspecific cellular immune response effect was less 
obvious, but an increased middle cells number. This before mentioned aspect might suggest a 
specific anticancer response. 
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Despite the fact that VA had no influence in the variation of the body weight, injected 
before EAC, the cytotoxic and antiproliferative effects were still ascertained by significant 
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